Assess applications and implement if endorsed funding of new products and services and changes to existing products and services for the Australian blood sector in accordance with Schedule 4 of the National Blood Agreement Assess applications and implement if endorsed funding of new products and services and changes to existing products and services for the Australian blood sector in accordance with Schedule 4 of the National Blood Agreement Assess applications and implement if endorsed funding of new products and services and changes to existing products and services for the Australian blood sector in accordance with Schedule 4 of the National Blood Agreement Assess applications and implement if endorsed funding of new products and services and changes to existing products and services for the Australian blood sector in accordance with Schedule 4 of the National Blood Agreement Immunoglobulin Governance Monitor and improve distribution and inventory arrangements for Ig products Monitor and improve distribution and inventory arrangements for Ig products Monitor and improve distribution and inventory arrangements for Ig products Monitor and improve distribution and inventory arrangements for Ig products KEY PERFORMANCE INDICATORS products are available to meet clinical need. Collection and production yield for domestic immunoglobulin maximised. Discards as a percentage of net issues of red blood cells less than 2.5%. Variance between actual and NBA estimated demand for supply of products is less than 5%.
Implement and review the revised planning cycle for the NBA Business Plan, Corporate Plan and Performance Reporting Statement Implement and review the revised planning cycle for the NBA Business Plan, Corporate Plan and Performance Reporting Statement Implement and review the revised planning cycle for the NBA Business Plan, Corporate Plan and Performance Reporting Statement Implement and review the revised planning for the NBA Business Plan, Corporate Plan and Performance Reporting Statement Program 2018-19 2019-20 2020-21 2021-22 Corporate Governance and Management AAIs reviewed and mandatory training undertaken AAIs reviewed and mandatory staff training undertaken AAIs reviewed and mandatory staff training undertaken AAIs reviewed and mandatory training undertaken Develop the 2019-20 Corporate Plan Develop the 2020-21 Corporate Plan Develop the 2021-22 Corporate Plan Develop the 2022-23 Corporate Plan Develop a 2020 workforce planning strategy Implement 2020 workforce planning strategy Review and monitor 2020 workforce planning strategy Blood Sector Knowledge and Development NBA attendance at relevant domestic and international conferences for 2018-19 NBA attendance at relevant domestic and international conferences for 2019-20 NBA attendance at relevant domestic and international conferences for 2020-21 NBA attendance at relevant domestic and international conferences for 2021-22 KEY PERFORMANCE INDICATORS Continue to be an employer of choice with a staff retention rate of 80%. Maintain a safe and healthy work environment with a reportable incident rate less than 2%. All annual APS mandatory learning and development modules can be completed online by NBA